Drug Profile
LPT 99
Alternative Names: LPT-99Latest Information Update: 28 Jan 2022
Price :
$50
*
At a glance
- Originator Loop Therapeutics
- Developer Spiral Therapeutics
- Class Small molecules
- Mechanism of Action Apoptotic protease activating factor 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hearing loss
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for phase-I development in Hearing loss(In volunteers) in Australia (Intratympanic)
- 28 Oct 2021 No recent reports of development identified for preclinical development in Hearing loss in USA (Otic, Gel)
- 24 Sep 2019 Spiral Therapeutics completes a phase-I clinical trials in Hearing loss (In volunteers) in Australia (Intratympanic) (ACTRN12618001461280p)